This report describes and evaluates the implementation of an innovative programme to help patients diagnosed with either early-stage localised prostate cancer or Benign Prostatic Hyperplasia (BPH) to reach ‘good quality’ decisions about their treatment in partnership with healthcare professionals. The programme was implemented in the urology departments of four NHS Hospital Trusts in England and was monitored and evaluated by researchers at Picker.